Clinical Trial Update: A Study of CP-4126 in Patients With Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of CP-4126 in patients with advanced pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• CP-4126 (CP-4126)

Snippet

Sponsor: Clavis Pharma | Conditions: Advanced Adenocarcinoma of Pancreas | Phase 2 | Status: COMPLETED